Cellectar Biosciences (CLRB) Misses Q3 EPS by 7c

Cellectar Biosciences (NASDAQ: CLRB) reported Q3 EPS of ($0.40), $0.07 worse than the analyst estimate of ($0.33).

For earnings history and earnings-related data on Cellectar Biosciences (CLRB) click here.

You May Also Be Interested In

• SanDisk upgraded at JPMorgan after investor day; shares climb
• Bernstein SocGen Group Reiterates Outperform Rating on Adyen NV (ADYEN:NA) (ADYYF), 'Can we now also get some AI winner premium?'
• StablecoinX reports Q2 2026 results with $34.2M net loss